Establishment of Online Registration Platform for Unruptured Intracranial Aneurysms Based on 100 Regional Medical Centers in China and Population Follow-up Study

NCT04872842 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2022-11-08

No results posted yet for this study

Summary

In this study, 20 regional neurosurgery centers across the country will be included, and the study cohort will be constructed on the basis of the IARP-CP cohort.The artificial intelligence platform was used to analyze the clinical, morphological, hemodynamics, aneurysm wall characteristics and other factors of unruptured aneurysms, as well as the relationship between these factors and the risk of aneurysm instability, seek the potential risk factors, and finally establish a multi-dimensional prediction model of rupture risk of intracranial aneurysms.

Conditions

  • Intracranial Aneurysm

Interventions

OTHER

Obervation

This study is an observational study without any intervention

Sponsors & Collaborators

  • Beijing Hospital

    collaborator OTHER_GOV
  • Peking University Third Hospital

    collaborator OTHER
  • Beijing Sanbo Brain Hospital

    collaborator OTHER
  • Beijing Chao Yang Hospital

    collaborator OTHER
  • Binzhou Renmin Hospital

    collaborator UNKNOWN
  • Fujian Medical University Union Hospital

    collaborator OTHER
  • First Affiliated Hospital of Fujian Medical University

    collaborator OTHER
  • Guangzhou Red Cross Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Haerbin Medical University

    collaborator UNKNOWN
  • The Affiliated Hospital of Qingdao University

    collaborator OTHER
  • Shanxi Provincial People's Hospital

    collaborator OTHER_GOV
  • Beijing Tsinghua Changgeng Hospital

    collaborator OTHER
  • RenJi Hospital

    collaborator OTHER
  • Sichuan Provincial People's Hospital

    collaborator OTHER
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER
  • The Affiliated Hospital of Kunming Medical University

    collaborator UNKNOWN
  • Beijing Unimed Technology Company

    collaborator UNKNOWN
  • Beijing Tiantan Hospital

    lead OTHER

Principal Investigators

  • Shuo Wang, MD · Beijing Tiantan Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2022-03-01
Completion
2022-05-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04872842 on ClinicalTrials.gov